Company Description
Braskem S.A., together with its subsidiaries, produces and sells thermoplastic resins.
The company produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; intermediates, such as cumene, paraxylene, ortho-xylene, and others; polyethylene (PE) and polypropylene (PP); polyvinyl chloride; hydrochloric acid, dichloroethane – EDC, and sodium hypochlorite; fuels, such as gasoline, boosters, and others; solvents, such as toluene, xylene, and other products; and specialties comprising polyisobutene, hydrocarbon resin, isoprene, dicyclopentadiene, piperylene, nonene, tetramer, green PE wax, and other products.
It also supplies electricity and other inputs to second-generation producers; produces and sells caustic soda; produces and sells ethylene, high-density PE, and low-density PE in Mexico; manufactures, sells, imports, and exports chemicals, petrochemicals, and fuels; and produces, supplies, and sells utilities, such as steam, water, compressed air, and industrial gases.
The company was formerly known as Copene Petroquímica do Nordeste S.A. and changed its name to Braskem S.A. in 2002.
Braskem S.A. was founded in 1972 and is headquartered in São Paulo, Brazil. Braskem S.A. operates as a subsidiary of Novonor S.A.
| Country | Brazil |
| Founded | 1972 |
| Industry | Chemicals |
| Sector | Materials |
| Employees | 8,569 |
| CEO | Roberto Prisco Ramos |
Contact Details
Address: Rua Lemos Monteiro, 120, 24o andar São Paulo, SP 05501-050 Brazil | |
| Phone | 55 11 3576 9000 |
| Website | braskem.com.br |
Stock Details
| Ticker Symbol | BAK |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | BRL |
| CIK Code | 0001071438 |
| CUSIP Number | 105532105 |
| ISIN Number | US1055321053 |
| SIC Code | 2860 |
Key Executives
| Name | Position |
|---|---|
| Roberto Prisco Paraíso Ramos | Chief Executive Officer |
| Felipe Montoro Jens | Chief Financial and Investor Relations Officer |
| João Henrique Rittershaussen | Executive Officer and Head of Investments and Digital Technologies |
| Cristiana Lapa | General Counsel and Corporate Governance Officer |
| Nir Lander | Chief Compliance Officer |
| Dr. Daniel P. MacEachran | Head of Metabolic Engineering |
| Rosana Avolio | Investor Relations Manager |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 19, 2024 | 6-K | Report of foreign issuer |
| Dec 16, 2024 | 6-K | Report of foreign issuer |
| Dec 11, 2024 | 6-K | Report of foreign issuer |
| Dec 11, 2024 | 6-K | Report of foreign issuer |
| Dec 10, 2024 | 6-K | Report of foreign issuer |
| Dec 10, 2024 | 6-K | Report of foreign issuer |
| Dec 4, 2024 | 6-K | Report of foreign issuer |
| Dec 3, 2024 | 6-K | Report of foreign issuer |
| Dec 2, 2024 | 6-K | Report of foreign issuer |
| Nov 29, 2024 | 6-K | Report of foreign issuer |